文献速递其他结缔组织病

深度免疫表型分析与聚类识别可预测原发性干燥病淋巴瘤的生物标志物

Deep Immunophenotyping and Clustering Identifies Biomarkers Predictive of Lymphoma in Primary Sjögren Disease.
PubMed 文献 · Arthritis Rheumatol · 2025-07-24

纳入206例符合ACR/EULAR 2016标准的原发性干燥病(pSD)患者,分为pSD、淋巴增殖性pSD(Arl-pSD)和NHL-pSD三组,采用深度流式细胞术免疫表型分析B/T细胞区室及血清IFNα定量。CD11c+ FcRL5+组织样记忆B细胞和IFNγ+ TNFα+常规T细胞与NHL显著相关,两群联合区分NHL-pSD的灵敏度78.9%、特异度76.8%。

要点

  • CD11c+ FcRL5+组织样记忆B细胞与IFNγ+ TNFα+常规T细胞与pSD患者发生NHL显著相关。
  • 两群联合区分NHL-pSD灵敏度78.9%、特异度76.8%,优于常规临床和生物学标志物之和。
  • CD11c+ FcRL5+组织样记忆B细胞与MALT边缘区NHL相关,IFNγ+ TNFα+常规T细胞更提示非MALT B细胞NHL。

核心结论

  • 基于深度免疫表型分析与临床、生物学及组织病理学数据整合分析,揭示了pSD中NHL的新生物标志物,并可区分pSD中的B细胞NHL亚型。

研究设计与样本

  • 纳入206例符合美国风湿病学会/EULAR 2016标准的pSD患者,分为pSD、淋巴增殖性pSD(Arl-pSD)和NHL-pSD三组。
  • 对B和T细胞区室进行深度流式细胞术免疫表型分析,并定量血清干扰素-α(IFNα),结合临床、生物学和组织病理学数据分析。

主要发现

  • CD11c+ FcRL5+组织样记忆B细胞和IFNγ+ TNFα+常规T细胞与pSD中的NHL显著相关。
  • 上述细胞群在Arl-pSD和NHL-pSD中较pSD呈渐进性富集。
  • 两群丰度联合区分NHL-pSD的灵敏度为78.9%、特异度为76.8%,单独即优于冷球蛋白血症血管炎、腮腺肿大、adapted EULAR Sjögren's Syndrome Disease Activity Index、类风湿因子抗体、低C4和血清IFNα升高这些常规临床和生物学标志物之和(分别为68.4%和78.0%)。
  • CD11c+ FcRL5+组织样记忆B细胞与黏膜相关淋巴组织(MALT)边缘区NHL的发生相关,而IFNγ+ TNFα+常规T细胞更提示非MALT B细胞NHL。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with primary Sjögren disease (pSD) are prone to develop non-Hodgkin lymphoma (NHL), but relevant biomarkers are lacking. We aimed to determine new biomarkers predictive of NHL in patients with pSD. METHODS: Two hundred six patients with pSD fulfilling American College of Rheumatology/EULAR 2016 criteria were included and divided into three groups: pSD, lymphoproliferative pSD (Arl-pSD), and NHL-pSD. Deep flow cytometry immunophenotyping of B and T cell compartments as well as serum interferon-α (IFNα) quantification were coupled to clinical, biologic, and histopathologic data analysis. RESULTS: We identified CD11c+ FcRL5+ tissue-like memory B cells and IFNγ+ TNFα+ conventional T cells as significantly associated with NHL in pSD. These clusters showed progressive enrichment in Arl-pSD and NHL-pSD as compared to pSD. The combination of these two population abundances discriminates patients with NHL-pSD with a sensitivity of 78.9% and a specificity of 76.8%, thus overcoming alone the performance of the sum of conventional clinical and biologic markers such as cryoglobulinemia vasculitis, parotid enlargement, adapted clinical EULAR Sjögren's Syndrome Disease Activity Index, rheumatoid factor antibodies, low C4 and elevated serum IFNα levels (68.4% and 78.0%, respectively). CD11c+ FcRL5+ tissue-like memory B cells were associated with occurrence of mucosa-associated lymphoid tissue (MALT) marginal-zone NHL, whereas IFNγ+ TNFα+ conventional T cells were more indicative of non-MALT B cell NHL. CONCLUSION: We unveil novel biomarkers of NHL in pSD based on an integrative analysis coupling deep immunophenotyping and clinical, biologic, and histopathologic data. Furthermore, these markers allow distinguishing B cell NHL subtypes in pSD.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Marques C, Régnier P, Maciejewski-Duval A, et al. Deep Immunophenotyping and Clustering Identifies Biomarkers Predictive of Lymphoma in Primary Sjögren Disease. Arthritis Rheumatol. 2025. PMID: 40290096. doi:10.1002/art.43207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。